These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 17481638)

  • 1. Increased serum titers of autoantibodies against oxidized LDL cholesterol in young healthy adults.
    Karabinos I; Koulouris S
    Atherosclerosis; 2007 Jun; 192(2):448-50. PubMed ID: 17481638
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
    Soep JB; Mietus-Snyder M; Malloy MJ; Witztum JL; von Scheven E
    Arthritis Rheum; 2004 Jun; 51(3):451-7. PubMed ID: 15188333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
    Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG; Tertov VV; Orekhov AN
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA).
    Garrido-Sánchez L; García-Fuentes E; Rojo-Martínez G; Cardona F; Soriguer F; Tinahones FJ
    Br J Nutr; 2008 Sep; 100(3):585-9. PubMed ID: 18252023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidized LDL and anti-oxidized LDL antibodies according uric acid levels in overweight women].
    Ruíz-Hernández N; Espinoza-Zavala M; González JC; Leal-Herrera U; Reigosa-Yaniz A
    Arch Cardiol Mex; 2011; 81(3):188-96. PubMed ID: 21975232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidized LDL antibody levels are reduced in women with hypertension.
    Garrido-Sánchez L; García-Fuentes E; Cardona F; Rojo-Martínez G; Soriguer F; Tinahones FJ
    Eur J Clin Invest; 2009 Sep; 39(9):800-6. PubMed ID: 19674079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
    Gonçalves I; Cherfan P; Söderberg I; Nordin Fredrikson G; Jonasson L
    Autoimmunity; 2009 Mar; 42(3):203-8. PubMed ID: 19301201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against oxidized LDL and serum total antioxidant status in active cyclists and ex-cyclists.
    García-Unzueta MT; Gutiérrez-Sánchez JB; de Mier I; Amado JA; Berrazueta JR
    Horm Metab Res; 2003 Sep; 35(9):541-5. PubMed ID: 14517771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.